# ACRV (Acrivon Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Acrivon Therapeutics, Inc. reported $85.75M in total assets and a net loss of $73.89M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/ACRV
- Markdown: https://convexityos.com/fundamentals/ACRV.md
- SEC CIK: 0001781174
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:51 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001781174&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$77.20M | Operating profit |
| Net Income | FY 2025 | -$73.89M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$1.72 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$63.34M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $77.75M | Total debt: $1.80M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Research & Development | $59.99M | $63.99M | $46.02M | $23.95M | -- |
| Total Operating Expenses | $84.11M | $89.20M | $67.10M | $32.66M | $16.18M |
| **Operating Income** | -$84.11M | -$89.20M | -$67.10M | -$32.66M | -$16.18M |
| **EBITDA** | -$82.76M | -$88.19M | -$66.57M | -$32.29M | -$16.15M |
| Interest Income | -- | -- | $7.00M | $1.50M | -- |
| Income Before Tax | -$77.83M | -$80.44M | -- | -- | -- |
| Income Tax Expense | $0 | -- | -- | -- | -- |
| **Net Income** | -$77.91M | -$80.56M | -$60.39M | -$31.17M | -$16.24M |
| Basic EPS | -$2.02 | -$2.38 | -$2.74 | -$7.56 | -$9.32 |
| **Diluted EPS** | -$2.02 | -$2.38 | -$2.74 | -$7.56 | -$9.32 |
| Basic Shares Outstanding | 38.5M | 33.8M | 22.1M | 4.1M | 1.7M |
| Diluted Shares Outstanding | 38.5M | 33.8M | 22.1M | 4.1M | 1.7M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $14.55M | $13.84M | $15.17M | $14.75M | $13.65M | $16.18M | $15.41M | $18.63M |
| Total Operating Expenses | $18.52M | $18.67M | $19.90M | $20.12M | $19.69M | $22.65M | $21.66M | $24.95M |
| **Operating Income** | -$18.52M | -$18.67M | -$19.90M | -$20.12M | -$19.69M | -$22.65M | -$21.66M | -$24.95M |
| **EBITDA** | -$18.12M | -$18.27M | -$19.52M | -$19.75M | -$19.39M | -$22.35M | -$21.35M | -$24.65M |
| **Net Income** | -$17.90M | -$17.96M | -$19.04M | -$18.98M | -$18.23M | -$21.01M | -$19.68M | -$22.83M |
| Basic EPS | -$0.42 | -$0.43 | -$0.49 | -- | -$0.47 | -$0.55 | -$0.51 | -- |
| **Diluted EPS** | -$0.42 | -$0.43 | -$0.49 | -- | -$0.47 | -$0.55 | -$0.51 | -- |
| Basic Shares Outstanding | 42.9M | 41.8M | 38.7M | -- | 38.6M | 38.5M | 38.4M | -- |
| Diluted Shares Outstanding | 42.9M | 41.8M | 38.7M | -- | 38.6M | 38.5M | 38.4M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $41.50M | $39.82M | $36.02M | $29.52M | $99.60M |
| Short-Term Investments | $77.08M | $139.7M | $91.44M | $98.23M | -- |
| **Cash & Short-Term Investments** | $118.6M | $179.5M | $127.5M | $127.8M | $99.60M |
| **Total Current Assets** | $120.4M | $181.6M | $129.7M | $132.1M | $100.4M |
| Property, Plant & Equipment, Net | $4.89M | $4.47M | $3.48M | $2.09M | $290K |
| Long-Term Investments | -- | $5.09M | -- | $41.88M | -- |
| Other Non-Current Assets | $1.65M | $1.65M | $251K | -- | -- |
| **Total Non-Current Assets** | $9.27M | $14.96M | $8.57M | $49.13M | $6.18M |
| **Total Assets** | $129.7M | $196.6M | $138.3M | $181.2M | $106.6M |
| Accounts Payable | $2.28M | $758K | $5.05M | $904K | $964K |
| **Total Current Liabilities** | $15.66M | $17.21M | $13.30M | $6.52M | $2.91M |
| **Total Non-Current Liabilities** | $1.54M | $2.59M | $3.77M | $4.24M | $4.96M |
| **Total Liabilities** | $17.20M | $19.80M | $17.07M | $10.75M | $7.88M |
| **Total Debt (incl. Leases)** | $2.71M | $3.65M | $4.64M | $4.96M | $5.63M |
| Common Stock | $31K | $31K | $23K | $22K | $2.0K |
| Retained Earnings | -$274.9M | -$197.0M | -$116.4M | -$56.03M | -$24.86M |
| Accumulated Other Comp. Income | $111K | $447K | -$83K | -$95K | -- |
| **Total Stockholders' Equity** | $112.5M | $176.8M | $121.2M | $170.5M | -$23.81M |
| Total Equity | $112.5M | $176.8M | $121.2M | $170.5M | -$23.81M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $47.53M | $41.42M | $34.06M | $41.50M | $35.41M | $41.90M | $39.15M | $39.82M |
| Short-Term Investments | $30.22M | $48.54M | $63.67M | $77.08M | $93.85M | $95.53M | $110.5M | $139.7M |
| **Cash & Short-Term Investments** | $77.75M | $89.96M | $97.74M | $118.6M | $129.3M | $137.4M | $149.6M | $179.5M |
| **Total Current Assets** | $79.08M | $91.49M | $99.22M | $120.4M | $130.4M | $138.4M | $151.3M | $181.6M |
| Property, Plant & Equipment, Net | $3.83M | $4.25M | $4.65M | $4.89M | $5.19M | $5.07M | $4.68M | $4.47M |
| Long-Term Investments | -- | -- | -- | -- | $5.11M | $10.20M | $15.20M | $5.09M |
| Other Non-Current Assets | $945K | $1.18M | $1.51M | $1.65M | $1.65M | $1.65M | $1.65M | $1.65M |
| **Total Non-Current Assets** | $6.67M | $7.60M | $8.61M | $9.27M | $14.94M | $20.17M | $25.02M | $14.96M |
| **Total Assets** | $85.75M | $99.09M | $107.8M | $129.7M | $145.3M | $158.6M | $176.3M | $196.6M |
| Accounts Payable | $616K | $861K | $1.16M | $2.28M | $996K | $1.16M | $3.69M | $758K |
| **Total Current Liabilities** | $14.28M | $11.45M | $11.05M | $15.66M | $14.89M | $13.43M | $13.55M | $17.21M |
| **Total Non-Current Liabilities** | $693K | $980K | $1.26M | $1.54M | $1.80M | $2.12M | $2.41M | $2.59M |
| **Total Liabilities** | $14.97M | $12.43M | $12.32M | $17.20M | $16.70M | $15.55M | $15.96M | $19.80M |
| **Total Debt (incl. Leases)** | $1.80M | $2.12M | $2.42M | $2.71M | $2.99M | $3.26M | $3.51M | $3.65M |
| Common Stock | $42K | $42K | $38K | $31K | $31K | $31K | $31K | $31K |
| Retained Earnings | -$329.8M | -$311.9M | -$293.9M | -$274.9M | -$255.9M | -$237.7M | -$216.7M | -$197.0M |
| Accumulated Other Comp. Income | -$26K | -$33K | $4.0K | $111K | $112K | $106K | $283K | $447K |
| **Total Stockholders' Equity** | $70.77M | $86.67M | $95.52M | $112.5M | $128.6M | $143.0M | $160.4M | $176.8M |
| Total Equity | $70.77M | $86.67M | $95.52M | $112.5M | $128.6M | $143.0M | $160.4M | $176.8M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Net Income | -$77.91M | -$80.56M | -$60.39M | -$31.17M | -$16.24M |
| Depreciation & Amortization | $1.36M | $1.01M | $536K | $364K | $37K |
| Stock-Based Compensation | $14.72M | $14.29M | $11.62M | $2.19M | $497K |
| Change in Payables | $1.54M | -$3.59M | $3.61M | -$245K | $798K |
| **Operating Cash Flow** | -$63.66M | -$65.67M | -$42.64M | -$30.12M | -$13.98M |
| Capital Expenditure | -$1.67M | -$2.77M | -$1.29M | -$2.17M | -$238K |
| **Free Cash Flow** | -$65.33M | -$68.44M | -$43.93M | -$32.28M | -$14.22M |
| Purchases of Investments | -$81.73M | -$202.9M | -$56.53M | -$150.2M | -- |
| **Investing Cash Flow** | $66.10M | -$51.77M | $50.72M | -$141.7M | -$238K |
| **Financing Cash Flow** | -$749K | $121.0M | -$1.55M | $101.7M | $112.2M |
| **Net Change in Cash** | $1.69M | $3.59M | $6.52M | -$70.08M | $98.00M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$17.90M | -$17.96M | -$19.04M | -$18.98M | -$18.23M | -$21.01M | -$19.68M | -$22.83M |
| Depreciation & Amortization | $400K | $400K | $383K | $361K | $300K | $300K | $311K | $303K |
| Stock-Based Compensation | $2.00M | $2.21M | $2.18M | $3.09M | $3.91M | $3.93M | $3.79M | $3.71M |
| Change in Payables | -$245K | -$214K | -$1.20M | $1.28M | -$9.0K | -$2.55M | $2.82M | -$231K |
| **Operating Cash Flow** | -$12.38M | -$14.86M | -$20.54M | -$15.24M | -$12.28M | -$16.61M | -$19.54M | -$17.36M |
| Capital Expenditure | $0 | -$87K | -$14K | -$219K | -$899K | -$493K | -$58K | -$827K |
| **Free Cash Flow** | -$12.38M | -$14.95M | -$20.55M | -$15.46M | -$13.18M | -$17.10M | -$19.59M | -$18.19M |
| Purchases of Investments | $0 | -$9.97M | -$16.86M | -$13.26M | -$33.19M | -$15.06M | -$20.23M | -$34.76M |
| **Investing Cash Flow** | $18.50M | $14.95M | $13.13M | $21.52M | $5.91M | $19.45M | $19.21M | $14.41M |
| **Financing Cash Flow** | $0 | $7.27M | -$33K | -$192K | -$117K | -$97K | -$343K | -$647K |
| **Net Change in Cash** | $6.12M | $7.35M | -$7.44M | $6.09M | -$6.49M | $2.74M | -$664K | -$3.60M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -69.2% | -45.6% | -49.8% | -18.3% | -- |
| Return on Assets (ROA) | -60.1% | -41.0% | -43.7% | -17.2% | -15.2% |
| Current Ratio | 7.69x | 10.55x | 9.75x | 20.27x | 34.46x |
| Quick Ratio | 7.57x | 10.43x | 9.58x | 19.61x | 34.18x |
| Debt to Equity | 0.02x | 0.02x | 0.04x | 0.03x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -104.4% | -85.6% | -80.9% | -69.2% | -63.6% | -60.1% | -52.2% | -45.6% |
| Return on Assets (ROA) | -86.2% | -74.9% | -71.7% | -60.1% | -56.3% | -54.2% | -47.5% | -41.0% |
| Current Ratio | 5.54x | 7.99x | 8.98x | 7.69x | 8.75x | 10.31x | 11.17x | 10.55x |
| Quick Ratio | 5.44x | 7.86x | 8.84x | 7.57x | 8.68x | 10.23x | 11.04x | 10.43x |
| Debt to Equity | 0.03x | 0.02x | 0.03x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
